INFLUENCE OF STATIN THERAPY ON GALECTIN-3, VASCULAR ENDOTHELIAL GROWTH FACTOR, AND CARDIOVASCULAR RISK IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Borys Samura, 297932

EFFICACY OF POLYCHEMOTHERAPY IN TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA IN THE AGE OF NEW AGENTS

EHA Library, Xabier Gutiérrez Lopez de Ocáriz, 297933

LIGHTHOUSE (OP-108): A PHASE 3 STUDY OF MELFLUFEN IN COMBINATION WITH DARATUMUMAB VERSUS DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, María-Victoria Mateos, 297934

HEALTH-RELATED QUALITY OF LIFE OUTCOMES FROM THE PHASE 3 CANDOR STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

EHA Library, Katja Weisel, 297935

PROGNOSTIC IMPACT OF RAPID REDUCTION OF INVOLVED FREE LIGHT CHAINS DURING FIRST LINE THERAPY WITH BENDAMUSTINE, PREDNISONE AND BORTEZOMIB (BPV) IN MYELOMA PATIENTS

EHA Library, Tanja Holzhey, 297936

A RETROSPECTIVE OBSERVATIONAL STUDY OF THE TREATMENT OF MULTIPLE MYELOMA IN ROUTINE CLINICAL PRACTICE IN NORTH ESTONIAN MEDICAL CENTER 2009 - 2016.

EHA Library, Liva Andersone, 297937

MULTIPLE MYELOMA IN PORTUGAL: INCIDENCE, PREVALENCE, MORTALITY AND TREATMENT PATTERN

EHA Library, RUI FILIPE BERGANTIM, 297938

A MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PROGRESSION-FREE SURVIVAL BETWEEN ELOTUZUMAB, DARATUMUMAB, AND PANOBINOSTAT TRIPLET REGIMENS FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Clara Chen, 297939

QUANTIFICATION OF HEAVY + LIGHT CHAIN PAIRS AS POTENTIAL TECHNIQUE FOR QUICK AND ACCURATE MULTIPLE MYELOMA RESPONSE ASSESSMENT: A PROSPECTIVE STUDY

EHA Library, Karla Vallejo, 297940

RDW IS A PROGNOSTIC FACTOR IN AUTOLOGOUS STEM CELL TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

EHA Library, Susana Gonçalves Pereira, 297942

RENAL AND CARDIAC TOXICITY ASSOCIATED WITH CARFILZOMIB TREATMENT IN RRMM.

EHA Library, Stephanie Guidez, 297943

REAL LIFE EFFECTIVENESS OF VENETOCLAX BASED THERAPY IN HEAVILY PRE-TREATED PATIENTS WITH PLASMA CELL DYSCRASIA

EHA Library, Efrat Luttwak, 297944

THE MYELOMA LANDSCAPE IN AUSTRALIA AND NEW ZEALAND (ANZ): THE FIRST SEVEN YEARS OF THE MYELOMA AND RELATED DISEASES REGISTRY (MRDR)

EHA Library, Krystal Bergin, 297945

THROMBOEMBOLIC DISEASE INCIDENCE IN MULTIPLE MYELOMA PATIENTS.RETROSPECTIVE EXPERIENCE OF 2 SPANISH CENTERS.

EHA Library, Luis Miguel Juárez-Salcedo, 297946

NON-INVASIVE AND AFFORDABLE FIRST-STEP DIAGNOSTIC TEST FOR THE EARLY DIAGNOSIS OF GAUCHER’S DISEASE IN PATIENTS WITH MONOCLONAL GAMMAPATHIES (MGUS OR MYELOMA): MONOCENTRIC OBSERVATIONAL STUDY

EHA Library, Giuseppe Mele, 297947

THERAPY REGIMENS INCLUDING DARATUMUMAB FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: REPORT FROM THE MULTIPLE MYELOMA GIMEMA LAZIO GROUP

EHA Library, Francesca Fazio, 297948

REAL LIFE DATA OF PROGNOSTIC MINIMAL RESIDUAL DISEASE EVALUATION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

EHA Library, ROSSELLA RIBOLLA, 297949

MULTIPLE MYELOMA WITH FISH-IDENTIFIED TP53 DELETION: A REAL-WORLD EXPERIENCE OF 103 PATIENTS

EHA Library, András Kozma, 297950

CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA

EHA Library, Claudio Cerchione, 297951

REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN MULTIPLE MYELOMA IN THE ASIA-PACIFIC REGION: PRELIMINARY RESULTS OF THE ASIA-PACIFIC MYELOMA AND RELATED DISEASES REGISTRY

EHA Library, Andrew Spencer, 297952

IMPACT OF OVERALL POPULATION HEALTH ON SURVIVAL IN MULTIPLE MYELOMA

EHA Library, Lewis McCheyne, 297953

DREAMM-9: PHASE III STUDY OF BELANTAMAB MAFODOTIN PLUS VRD VS. VRD ALONE IN TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA (TI NDMM)

EHA Library, Saad Z. Usmani, 297954

ADVERSE EVENT AND OUTCOME PATTERNS IN PATIENTS WITH ADVANCED MULTIPLE MYELOMA IN THE US

EHA Library, Joshua Richter, 297955

“REAL WORLD” BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE COMBINATION IN TRANSPLANT INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Helene Gardeney, 297956

DREAMM-3: PHASE III, OPEN-LABEL, RANDOMIZED STUDY OF SINGLE-AGENT BELANTAMAB MAFODOTIN VERSUS POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE (POM/DEX) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Katja Weisel, 297957

TREATMENT RESPONSE WITHOUT TWO CONSECUTIVE ASSESSMENTS OF TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: A SUPPLEMENTARY ANALYSIS OF JCOG1105

EHA Library, Nobuhiko Nakamura, 297958

CHANGES IN THE TREATMENT LANDSCAPE OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND THEIR ASSOCIATION WITH MORTALITY: INSIGHTS FROM A LARGE GERMAN CLAIMS DATABASE

EHA Library, Christof Scheid, 297959

PREDICTORS OF RENAL RECOVERY IN PATIENTS OF NEWLY DIAGNOSED MULTIPLE MYELOMA PRESENTING WITH RENAL IMPAIREMENT IN REAL WORLD

EHA Library, RINTU SHARMA, 297960

PATIENT SIMILARITY ANALYSIS AND VISUALIZATION IN MULTIPLE MYELOMA

EHA Library, Joanne Joseph, 297961

IDENTIFICATION OF DYNAMIC BIOMARKERS OF RESPONSE TO PANOBINOSTAT CONSOLIDATION IN MM PATIENTS WITH A SUBOPTIMAL RESPONSE FOLLOWING UPFRONT ASCT (PANO-MONO STUDY)

EHA Library, Anna Kalff, 297962

SIGNIFICANCE OF PROGNOSTIC EVALUATION BASED ON TREATMENT EFFECT AT 6 MONTHS IN LENALIDOMIDE PLUS DEXAMETHASONE THERAPY

EHA Library, Naoki Takezako, 297963

PROGRESSIVE RELAPSES ARE ASSOCIATED WITH SHORTER TTNT AND PFS IN MULTIPLE MYELOMA PATIENTS IN AN ASIAN POPULATION

EHA Library, Cinnie Soekojo, 297964

BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE (BVD) IN HEAVILY PRETREATED MULTIPLE MYELOMA: OLD/NEW IN NOVEL AGENTS' ERA

EHA Library, Claudio Cerchione, 297965

REAL-WORLD, MULTI-CENTRE REVIEW OF THE EFFECTIVENESS OF DARA MONOTHERAPY AND PATIENTS’ RESPONSE TO SUBSEQUENT THERAPIES

EHA Library, Matthew Holt, 297966

VENETOCLAX PLUS BORTEZOMIB AND DEXAMETHASONE IN HEAVILY PRETREATED END-STAGE MYELOMA PATIENTS WITHOUT T(11;14): A REAL-WORLD COHORT

EHA Library, Tomas Jelínek, 297967

HOW TO PREVENT PNEUMONIAS IN PATIENTS WITH MULTIPLE MYELOMA ON NOVEL AGENTS: THE NEW REGIMEN OF PNEUMOCOCCAL VACCINATION

EHA Library, Igor Stoma, 297968

EXPERIENCE WITH THE USE OF ANTITUMOR PROGRAMS OF VMP (BORTEZOMIB, MELPHALANE, PREDNISOLONE) AND RVP (LENALIDOMIDE, BORTEZOMIB, PREDNISOLONE) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Кирилл Белоусов, 297969

CLINICO-PATHOLOGICAL PROFILE AND TREATMENT OUTCOME OF MULTIPLE MYELOMA: FIRST REPORT FROM QATAR

EHA Library, Hesham El Sabah, 297970

OPEN-LABEL PILOT STUDY OF GENETICALLY ENGINEERED NY-ESO-1–SPECIFIC T CELLS (GSK3377794) ALONE OR IN COMBINATION WITH PEMBROLIZUMAB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Jonathan L Kaufman, 297971

BORTEZOMIB BASED CHEMOTHERAPY FOR INDUCTION THERAPY FOLLOWED BY IXAZOMIB-DEXAMETHASONE IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Man Shen, 297972

CARFILZOMIB-RELATED LONG TERM CARDIAC TOXICITIES IN ASYMPTOMATIC PATIENTS.

EHA Library, Veronica Mattiello, 297973

LIGHT-CHAIN AMYLOIDOSIS IN LATIN AMERICA. DIAGNOSIS AND FRONTLINE TREATMENT.

EHA Library, Eloísa Riva, 297974

CLINICAL IMPACT OF SPINE MRI AS A VALUABLE PROGNOSTIC TOOL FOR PATIENTS WITH NEWLY DIAGNOSED WITH MULTIPLE MYELOMA

EHA Library, Dong Won Baek, 297975

REAL LIFE USE AND OUTCOMES OF POMALIDOMIDE BASED ANTI-MYELOMA THERAPIES AN ANALYSIS FROM THE AUSTRIAN MYELOMA REGISTRY (AMR)

EHA Library, Eva Wallner, 297976

VARIETIES OF THE EXTRAMEDULLARY PLASMA CELL NEOPLASIA: CLINICAL FEATURES AND PROGNOSTIC IMPACT

EHA Library, Vladislava Djurasinovic, 297977

MULTIPLE MYELOMA IN REAL-WORLD CLINICAL PRACTICE: IMPACT OF TRANSPLANT ON SURVIVAL

EHA Library, AHMAD ALGHOCHE, 297978

ANALYZING THE STATUS OF HEMATOLOGIC MALIGNANCIES IN KOREA USING 2005-2015 NATIONAL HEALTH INSURANCE DATA; STATUS OF PROGRESS FROM MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE TO MULTIPLE MYELOMA

EHA Library, Min Jin Kim, 297979

DREAMM-1: PATIENT PERSPECTIVES FROM THE FIRST-IN-HUMAN STUDY OF SINGLE-AGENT BELANTAMAB MAFODOTIN FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Laurie Eliason, 297980

DREAMM-5 PLATFORM TRIAL: BELANTAMAB MAFODOTIN IN COMBINATION WITH NOVEL AGENTS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, PAUL RICHARDSON, 297981

PROSPECTIVE ANALYSIS OF AMYLOIDOSIS INCIDENCE IN THE UNIVERSITY TEACHING HOSPITAL IN WROCŁAW – SINGLE CENTRE EXPERIENCE

EHA Library, Magdalena Olszewska-Szopa, 297982

CHRONIC KIDNEY DISEASE AND RESPIRATORY PATHOLOGY AS A PREDICTOR OF INFECTIOUS COMPLICATIONS OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Evgeniy Mikhailov, 297983

CLINICAL PROFILE AND TREATMENT OUTCOMES OF AL AMYLOIDOSIS PATIENTS WITH CARDIAC INVOLVEMENT

EHA Library, Aditya Jandial, 297984

RECOMBINANT HUMAN THROMBOPOIETIN MAY ACCELERATE BONE MARROW HEMATOPOIETIC RECONSTRUCTION IN AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA IN NOVEL-AGENT ERA

EHA Library, Guangzhong Yang, 297985

OUTCOMES OF MAINTENANCE THERAPY USING LENALIDOMIDE OR BORTEZOMIB IN MULTIPLE MYELOMA PATIENTS POST AUTOLOGUS STEM CELL TRANSPLANTATION

EHA Library, Haitham Abdelbary, 297986

TREATMENT PATTERNS AND CLINICAL OUTCOMES IN NON-TRANSPLANT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) IN SPAIN

EHA Library, Dasha Cherepanov, 297987

EFFECTIVENESS OF HEMADSORPTION IN REDUCING FREE LIGHT CHAINS IN PATIENTS WITH MULTIPLE MYELOMA.

EHA Library, Aleksandr Fomin, 297988

THIRTY-FIVE CASES OF WALDENSTRÖM MACROGLOBULINEMIA: TEN YEARS’EXPERIENCE FROM A SINGLE CENTER.

EHA Library, Silvia Garcia Canales, 297989

CLINICOPATHOLOGIC SPECTRUM OF WALDENSTROM’S MACROGLOBULINEMIA: A SINGLE CENTER EXPERIENCE

EHA Library, Sanjeev Yadav, 297990

HIGH-DOSE VS STANDARD THERAPY IN PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA AGED 65-75 YEARS: A RETROSPECTIVE ANALYSIS

EHA Library, Massimo Offidani, 297991

DYNAMIC ASSESSMENT OF THE PROGRESSION RISK OF MGUS PATIENTS BASED ON FREE LIGHT CHAINS AND HEAVY LIGHT CHAINS BIOMARKERS

EHA Library, Tiago Pais, 297992

CBD REGIMEN PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANT FOLLOWED BY WEEKLY BD CONSOLIDATION AND RD MAINTENANCE FOR NEWLY DIAGNOSED MULTIPLE MYELOMA; PHASE Ⅱ STUDY OF NBMTG ASCT1201

EHA Library, Naoto Imoto, 297993

MONOCLONAL IMMUNOGLOBULINS PROGNOSTIC SIGNIFICANCE FOR THE EVALUATION OF SENSITIVITY TO LENALIDOMIDE-DEXAMETHASONE (RD) TREATMENT

EHA Library, Annita-Ioanna Gkioka, 297994

CLINICAL PROFILE OF MULTIPLE MYELOMA PATIENTS WITH LONG TERM SURVIVAL

EHA Library, Marta Raimondo, 297995

MULTIPLE MYELOMA WITH AND WITHOUT EXTRAMEDULLARY INVOLVEMENT: COMPARATIVE STUDY OF EPIDEMIOLOGIC, RADIOLOGICALY, THERAPEUTIC AND OUTCOME CHARACTERISTICS

EHA Library, Malek Sayadi, 297996

СYTOGENETIC STUDY OF BONE MARROW IN PATIENTS WITH MULTIPLE MYELOMA IN THE REAL CLINICAL PRACTICE (RESULTS OF RUSSIAN MULTICENTER STUDY)

EHA Library, Maxim Solovev, 297997

18F-FDG PET/LOW DOSE CT AS UNIQUE IMAGING TECHNIQUE TO ASSESS BONE INVOLVEMENT IN MULTIPLE MYELOMA PATIENTS

EHA Library, Carla Minoia, 297998

FEASIBILITY OF TANDEM AUTOLOGOUS STEM CELL TRANSPLANT FOR HIGH RISK MULTIPLE MYELOMA AT A SINGLE UK CENTRE

EHA Library, Huw Richards, 297999

COMPARISON OF EFFICACY, SAFETY, PATIENTS’ QUALITY OF LIFE AND DOCTORS' OCCUPATIONAL STRESS BETWEEN LENALIDOMIDE BASED AND BORTEZOMIB BASED INDUCTION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Juan Li, 298000

REAL WORLD EXPERIENCE WITH LENALIDOMIDE DEXAMETHASONE DOUBLET THERAPY IN 278 HUNGARIAN PATIENTS

EHA Library, Gergely Varga, 298001

EFFICACY AND SAFETY OF DARATUMUMAB IN THE TREATMENT OF RELAPSED/ REFRACTORY MULTIPLE MYELOMA, LOCAL EXPERIENCE FROM SAUDI ARABIA

EHA Library, Muteb Althomali, 298002

COMORBIDITY IN MULTIPLE MYELOMA IN REAL CLINICAL PRACTICE

EHA Library, Natalia Skvortsova, 298003

LENALIDOMIDE MAINTENANCE THERAPY IN MULTIPLE MYELOMA: A REAL-LIFE SINGLE CENTRE EXPERIENCE

EHA Library, Carolina Afonso, 298004

PROFILE OF RENAL INVOLVEMENT IN MULTIPLE MYELOMA AND ITS REVERSIBILITY WITH BORTEZOMIB BASED TRIPLE DRUG CHEMOTHERAPY

EHA Library, Tribikram Panda, 298005

VCD COMBINATION PRIOR TO VRD TREATMENT IN TRANSPLANT INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA.

EHA Library, Helene Gardeney, 298006

VCD VERSUS VRD-BASED REGIMENS AS FIRST LINE THERAPIES IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE MYELOMA (MM): RETROSPECTIVE MULTICENTER ANALYSIS

EHA Library, Olga Novosad, 298007

PLASMA CELL LEUKEMIA. A 12-YEAR SINGLE CENTER EXPERIENCE.

EHA Library, Javier Alberto Rojas Martínez, 298008

USE OF DIRECT ORAL ANTICOAGULANTS AS PRIMARY OR SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH MULTIPLE MYELOMA ON IMMUNOMODULATORY DRUGS

EHA Library, Carlos Aguilar, 298009

SALVAGE TREATMENT WITH SECOND AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT IN THE MULTIPLE MYELOMA RELAPSE/REFRACTORY SETTING

EHA Library, Luis Miguel Silva, 298010

DARATUMUMAB AS SINGLE AGENT IN RELAPSED REFRACTORY MYELOMA PATIENTS: A RETROSPECTIVE REAL-LIFE SURVEY

EHA Library, Uros Markovic, 298011

EFFICACY AND TOXICITY OF COMBINATION POMALIDOMIDE-CYCLOPHOSPHAMIDE-DEXAMETHASONE IN THE TREATMENT OF REFRACTORY RECURRENT MULTIPLE MYELOMA (RRMM) AT MOSCOW CITY CENTER FOR HEMATOLOGY

EHA Library, Yulia Kochkareva, 298012

SUBCUTANEOUS BORTEZOMIB, THALIDOMIDE AND DEXAMETHASONE PRIOR TO AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA. A RETROSPECTIVE ANALYSIS OF THE CATALAN INSTITUTE OF ONCOLOGY (ICO).

EHA Library, David Jimenez Ruiz De La Torre, 298013

ALLOGENEIC STEM CELL TRANSPLANTATION AFTER COMBINATION OF POMALIDOMIDE AND TEMOZOLOMIDE IN MULTIPLE MYELOMA WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT: A CASE STUDY

EHA Library, Omer Ekinci, 298014

NEWLY DIAGNOSED MULTIPLE MYELOMA < 70 – ROUTINE CLINICAL DATA

EHA Library, Joana Santos, 298015

MULTIPLE MYELOMA: RETROSPECTIVE ANALYSIS OF PATIENT RECORDS FROM A HOSPITAL-BASED CANCER REGISTRY AT A SINGLE BRAZILIAN CANCER CENTER

EHA Library, FERNANDA MOURA, 298016

THE ROLE OF DARATUMUMAB, LENALIDOMIDE AND DEXAMETASONE (DRD) IN ACHIEVING DIALYSIS-INDEPENDENCE IN RELAPSING/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)

EHA Library, Joana Oliveira, 298017

BONE DISEASE AS THE FIRST MANIFESTATION OF SYSTEMIC AL-AMYLOIDOSIS

EHA Library, Irina Rekhtina, 298018

EPIDEMIOLOGICAL DATA ON MULTIPLE MYELOMA IN ALBANIA

EHA Library, Tatjana Caja, 298019

EPIDEMIOLOGICAL, CLINICAL, THERAPEUTIC AND PROGRESSIF PROFILE OF 129 CASES OF MULTIPLE MYELOMA

EHA Library, hajar khibri, 298020

PROGRESSION OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) TO HAEMATOLOGICAL MALIGNANCY: A SYSTEMATIC REVIEW

EHA Library, Stephen James Quinn, 298021

REAL WORLD USE OF TRANSITIONING FROM BORTEZOMIB TO IXAZOMIB WITH NEWLY DIANOSED MULTIPLE MYELOMA

EHA Library, Yuping Zhong, 298022

SURVIVAL IMPROVEMENT OF OLDER PATIENTS WITH MULTIPLE MIELOMA IN THE ERA OF NOVEL AGENTS. ONE CENTER EXPERIENCE.

EHA Library, Maria Stefania Infante, 298023

POMALIDOMIDE IN MULTIPLE MYELOMA, DESCRIPTIVE ANALYSIS OF OUR EXPERIENCE

EHA Library, Olga Perez-Lopez, 298024

REAL WORLD USE OF POMALIDOMIDE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: CROATIAN EXPERIENCE

EHA Library, Josip Batinić, 298025

POMALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF HEAVILY PRETREATED MULTIPLE MYELOMA

EHA Library, Claudio Cerchione, 298026

DETERMINANTS OF PERSISTENT IN VIVO PLATELET ACTIVATION IN ASPIRIN-TREATED POLYCYTHEMIA VERA PATIENTS

EHA Library, Paola Ranalli, 298027

CLINICAL ASPECT OF PRECISE DIAGNOSIS IN PATIENTS WITH ERYTHROCYTOSIS

EHA Library, Aleša Kristan, 298028

MOLECULAR PROFILE OF CALR POSITIVE MYELOFIBROSIS: A SINGLE CENTER EXPERIENCE

EHA Library, Daniela Pereira Coelho, 298029

ASSOCIATION OF 46/1 HAPLOTYPE AND V617F MUTATION IN THE JANUS KINASE 2 GENE (JAK2): GENDER AND AGE MATTER

EHA Library, Igor Olkhovskiy, 298030

CONTEMPORARY HFE AND ASXL1 MUTATION IN A PATIENT WITH IDIOPATHIC ERYTHROCYTOSIS

EHA Library, Giacomo Biagetti, 298031

TWO CASES OF MYELOPROLIFERATIVE NEOPLASM WITH DUAL POSITIVITY ( BCR-ABL AND JAK-2)

EHA Library, Amarjot Kaur, 298032